What is the most appropriate test in detecting prostate cancer in patients with intermediate prostate specific antigen levels?

Authors

  • Daryoush Saedi Iran University of Medical Sciences. Radiology Department, Hasheminejhad Hospital
  • Hassan Jafari Iran University of Medical Sciences.
  • Hooman Bakhshandeh Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences,
  • Iman Mohseni Iran University of Medical Sciences.
  • Majid Chalian Iran University of Medical Sciences, Tehran, Iran.
Abstract:

  Abstract   Background: Regarding the variety of tests present for detecting and also screening   prostate cancer and also bearing in mind the advantages and disadvantages of   these tests we decided to re-evaluate these tests (total prostate specific antigen and all   of its modifications) in detecting prostate cancer in men with intermediate serum   PSAlevels.   Methods: Following a cross sectional study, 100 consecutive men with intermediate   serum PSA levels and normal digital rectal examination (DRE) were incorporated.   Total and free PSA levels and TRUS-guided systematic prostate biopsy were   performed. PSA density, percent free PSA and percent free PSA density were calculated and compared. Statistical analysis was carried out using STATA8 SE.   Results: Overall, 27 patients had prostate cancer and 73 had benign prostate pathology. PSA density had the greatest area under the curve (AUC) which was significantly higher than percent free PSA density (0.685 vs. 0.448, p<0.001). The AUC   of percent free PSA density was not different between benign and malignant biopsy   results nor was significantly higher than the AUC of percent free PSA (0.308) or any   other screening tests.   Conclusion: PSAdensity was the most accurate screening test for prostate cancer   in patients with PSA levels of 4-10 ng/ml and normal DRE. The percent free PSA   density was not significantly more accurate than percent free PSA and regarding the   costs of transrectal ultrasonography, it can be concluded that the percent free PSA is   more cost-effective and hence more appropriate than percent free PSA density to   screen prostate cancer.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

what is the most appropriate test in detecting prostate cancer in patients with intermediate prostate specific antigen levels?

abstract   background: regarding the variety of tests present for detecting and also screening prostate cancer and also bearing in mind the advantages and disadvantages of these tests we decided to re-evaluate these tests (total prostate specific antigen and all of its modifications) in detecting prostate cancer in men with intermediate serum psalevels.   methods: following a cross sectional st...

full text

Age Specific Reference Levels of Serum Prostate-Specific Antigen, Prostate Volume and Prostate Specific Antigen Density in Healthy Iranian Men

Background: It is relevant to highlight that there is not a precise and perfect report on either 95 percentile value (upper limit of normal range) or on appropriate reference intervals for serum PSA in Iranian population. Objective: To determine age-specific reference ranges for serum prostate-specific antigen (PSA) concentration and PSA density (PSAD) and prostate volumes in a population of he...

full text

Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

PURPOSE The most appropriate definition of biochemical progression after radical prostatectomy and radiation therapy is uncertain. We analyzed the effect of using various prostate specific antigen (PSA) end point definitions for defining biochemical progression after radical prostatectomy and attempted to determine the best PSA cut point to use. Aspects of the American Society for Therapeutic R...

full text

Prostate specific antigen staining intensity in prostatic adenocarcinoma correlates with serum prostate specific antigen , Bandar Abbas, Iran

Introduction: Prostatic adenocarcinoma is one the most common malignances and the second cause of death in males due to cancer. Prostate Specific Antigen (PZSA) serum level is the first marker to screen such patients. We aimed in this study, to assess the intensity of prostatic adenocarcinoma tissue staining with PSA staining method. Methods: In this corss-sectional study, prostatic adenocarcin...

full text

molecular detection of prostate specific antigen in patients with prostate cancer or benign prostate hyperplasia the first investigation from iran

prostate cancer is the second common form of cancer in men. detection of circulating prostate specific antigen (psa) transcripts has effectively been used for early diagnosis of prostate cancer cells. this investigation employed a reverse transcriptase polymerase chain reaction (rt-pcr) technique to distinguish the patients with either localized or metastatic prostate cancer (cap) vs. benign pr...

full text

age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy iranian men

background: it is relevant to highlight that there is not a precise and perfect report on either 95 percentile value (upper limit of normal range) or on appropriate reference intervals for serum psa in iranian population. objective: to determine age-specific reference ranges for serum prostate-specific antigen (psa) concentration and psa density (psad) and prostate volumes in a population of he...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 22  issue 4

pages  191- 197

publication date 2009-02

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023